22nd week of 2019 patent applcation highlights part 7 |
Patent application number | Title | Published |
20190159996 | MASCARA COMPOSITIONS COMPRISING A POLYMER HAVING CYCLIC AMIDE, CYCLIC AMINE AND ACRYLAMIDE FUNCTIONALITY | 2019-05-30 |
20190159997 | COMPOSITIONS COMPRISING POLYESTERS OF BIOLOGICAL ORIGIN AND BIOCOMPATIBLE INORGANIC COMPOUNDS, AND USES THEREOF IN THE COSMETIC FIELD | 2019-05-30 |
20190159998 | INTENSIVE HAIR CONDITIONER WITH POSITIVE EFFECT ON CURL DEFINITION | 2019-05-30 |
20190159999 | BIODEGRADABLE COPOLYMERS FOR COSMETIC USE | 2019-05-30 |
20190160000 | HAIR COLORING COMPOSITION FOR PROVIDING A FILM ON KERATIN FIBERS | 2019-05-30 |
20190160001 | COVALENT TREATMENT FOR KERATIN-CONTAINING MATERIALS | 2019-05-30 |
20190160002 | PROCESS FOR PREPARING STERILE ARIPIPRAZOLE FORMULATION | 2019-05-30 |
20190160003 | COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION OR INFECTION OF THE EYE | 2019-05-30 |
20190160004 | IMPROVEMENTS IN CANCER TREATMENT | 2019-05-30 |
20190160005 | Method of Preparing Solid Dispersions of Active Pharmaceutical Ingredients | 2019-05-30 |
20190160006 | 10-HYDROXYSTEARIC ACID COMPOSITIONS | 2019-05-30 |
20190160007 | Integrated Nano System for Liver-Targeting Co-Delivery of Genes/Drugs and Preparation Method | 2019-05-30 |
20190160008 | DRUG-CONTAINING FAT EMULSION AND METHOD FOR PRODUCING SAME | 2019-05-30 |
20190160009 | LIPOSOMAL COMPOSITION CONTAINING MILD ACIDIC ACTIVE AGENT | 2019-05-30 |
20190160010 | SOLID DRINK FOR REGULATING YANG-DEFICIENCY CONSTITUTION AND PROCESSING METHOD THEREOF | 2019-05-30 |
20190160011 | SOLID BEVERAGE FOR CONDITIONING YIN DEFICIENCY CONSTITUTION AND METHOD FOR PRODUCING THE SAME | 2019-05-30 |
20190160012 | COMPOSITION FOR SOLID PREPARATION, SOLID PREPARATION, AND METHOD FOR PRODUCING THE SAME | 2019-05-30 |
20190160013 | SLOW RELEASE COMPOSITION OF ACTIVE INGREDIENTS | 2019-05-30 |
20190160014 | Stable Solid Pharmaceutical Formulations Containing 2-(2-Nitro-4-Trifluoromethylbenzoyl)-1,3-Cylcohexanedione | 2019-05-30 |
20190160015 | MESOPOROUS SILICA NANOPARTICLES WITH A LIPID BILAYER COATING FOR CARGO DELIVERY | 2019-05-30 |
20190160016 | Anti-Parasitic Compositions and Methods | 2019-05-30 |
20190160017 | MEDICAL ACTIVE SUBSTANCE PATCH WITH REDUCED OPTICAL CONSPICUOUSNESS ON THE SKIN | 2019-05-30 |
20190160018 | MULTILAYERED EMULSION FILM AND METHOD FOR PREPARING THE SAME | 2019-05-30 |
20190160019 | ORAL DELIVERY SYSTEM COMPRISING TWO COMPARTMENTS | 2019-05-30 |
20190160020 | Transdermal Packaging Membranes | 2019-05-30 |
20190160021 | Substituted Stilbenes as Inhibitors of NF-kappaB and Activators of Nrf2 | 2019-05-30 |
20190160022 | COMPOSITION AND METHODS FOR TISSUE REGENERATION | 2019-05-30 |
20190160023 | USE OF CANNABIDIVARIN IN THE TREATMENT OF AUTISM SPECTRUM DISORDER, ASSOCIATED DISORDERS AND SCHIZOPHRENIA | 2019-05-30 |
20190160024 | USING EDIBLE CARRIERS TO PRODUCE CURCUMA EXTRACTS FOR ORAL AND TOPICAL USE | 2019-05-30 |
20190160025 | AGENTS USEFUL FOR TREATING OBESITY, DIABETES AND RELATED DISORDERS | 2019-05-30 |
20190160026 | TOPICAL COMPOSITIONS AND METHODS FOR MAKING AND USING SAME | 2019-05-30 |
20190160027 | SALBUTAMOL-CONTAINING OPHTHALMIC MEDICAMENT | 2019-05-30 |
20190160028 | PHARMACEUTICAL COMPOSITIONS WITH ANTIFLAVIVIRAL ACTIVITY | 2019-05-30 |
20190160029 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION | 2019-05-30 |
20190160030 | CARBOXYLIC ACIDS FOR EARLY CHILDHOOD APPLICATION | 2019-05-30 |
20190160031 | Use of Short Chain Fatty Acids in Cancer Prevention | 2019-05-30 |
20190160032 | TREATMENT OF VASCULOPATHY WITH PROSTACYCLIN AND MESENCHYMAL STEM CELLS | 2019-05-30 |
20190160033 | NOVEL AUTOPHAGY ACTIVATION-INDUCED COMPOUND FOR IMPROVING SKIN INFLAMMATION FOR AGING | 2019-05-30 |
20190160034 | USE OF APE1/REF-1 INHIBITORS IN COMBINATION THERAPIES FOR TREATMENT OF CANCER | 2019-05-30 |
20190160035 | METHOD OF TREATMENT | 2019-05-30 |
20190160036 | APPLICATION OF PHOSPHODIESTERASE 4 INHIBITOR ZL-N-91 IN PREPARATION OF MEDICAMENT FOR TREATING PROSTATE CANCER PROLIFERATION AND METASTASIS | 2019-05-30 |
20190160037 | METHOD OF TREATING, REDUCING, PREVENTING DETERIORATION OR IMPROVING VISUAL FUNCTION AFTER OPTIC NEUROPATHY | 2019-05-30 |
20190160038 | NANOPARTICLE ISOFLAVONE COMPOSITIONS & METHODS OF MAKING AND USING THE SAME | 2019-05-30 |
20190160039 | COMBINATION OF LOCAL AND SYSTEMIC THERAPIES FOR ENHANCED TREATMENT OF DERMATOLOGIC CONDITIONS | 2019-05-30 |
20190160040 | Heterocyclic Flavone Derivatives, Compositions, and Methods Related Thereto | 2019-05-30 |
20190160041 | Herbal Composition for The Treatment of Age Related Macular Diseases | 2019-05-30 |
20190160042 | METHOD FOR EVALUATING THE ABILITY OF A COMPOSITION TO PREVENT MUSCLE DAMAGE AND FATIGUE; FOOD SUPPLEMENT AND DRUG | 2019-05-30 |
20190160043 | DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF REM SLEEP BEHAVIOR DISORDER | 2019-05-30 |
20190160044 | TOPICAL PREPARATION FOR SKIN TISSUE PROTECTION AND REPARATION | 2019-05-30 |
20190160045 | SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS | 2019-05-30 |
20190160046 | NOVEL MODULATORS OF CALCIUM RELEASE-ACTIVATED CALCIUM CHANNEL | 2019-05-30 |
20190160047 | METHOD FOR TREATING OBESITY, DIABETES, CARDIOVASCULAR AND KIDNEY DISEASES BY REGULATING GPR30/GPER ACTIVITY | 2019-05-30 |
20190160048 | SUBSTITUTED 5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRIDINE-3(2H)-ONES AND 2,5,6,7-TETRAHYDRO-3H-PYRROLO[2,1-C][1,2,4]TRIAZOL-3-ONES, AND USE THEREOF | 2019-05-30 |
20190160049 | 2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXAMIDE COMPOUNDS AND THEIR USE AS DUAL INHIBITORS OF PDK1/AURA | 2019-05-30 |
20190160050 | SMALL MOLECULE INHIBITION FOR PREVENTING OR TREATING FIBROTIC DISEASES | 2019-05-30 |
20190160051 | METHODS FOR TREATING CANCER | 2019-05-30 |
20190160052 | INHIBITION OF BETA-2 NICOTINIC ACETYLCHOLINE RECEPTORS TO TREAT ALZHEIMER'S DISEASE PATHOLOGY | 2019-05-30 |
20190160053 | PHARMACEUTICAL FORMULATIONS FOR SUSTAINED RELEASE OF SEBACOYL DINALBUPHINE ESTER | 2019-05-30 |
20190160054 | PHARMACEUTICAL COMBINATION OF NINTEDANIB, TRIFLURIDINE AND TIPIRACIL FOR TREATING COLORECTAL CANCER | 2019-05-30 |
20190160055 | TRIPLE COMBINATION OF PURE 5-HT6 RECEPTOR ANTAGONISTS, ACETYLCHOLINESTERASE INHIBITORS AND NMDA RECEPTOR ANTAGONIST | 2019-05-30 |
20190160056 | HDAC1,2 INHIBITORS AND METHODS OF USING THE SAME | 2019-05-30 |
20190160057 | NEW TREATMENT FOR THE NON ALCOHOLIC STEATOHEPATITIS AND FIBROSIS | 2019-05-30 |
20190160058 | METHODS OF TREATMENT WITH SELECTIVE CB2 RECEPTOR AGONISTS | 2019-05-30 |
20190160059 | Compositions and Methods for Treating Metabolic Disorders | 2019-05-30 |
20190160060 | SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | 2019-05-30 |
20190160061 | 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS | 2019-05-30 |
20190160062 | 1,4-DISUBSTITUTED PYRIDAZINE QUINOLNE ANALOGS THERE OF AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS | 2019-05-30 |
20190160063 | NUCLEAR TRANSPORT MODULATORS AND USES THEREOF | 2019-05-30 |
20190160064 | METHODS FOR TREATING SKELETAL MUSCLE CACHEXIA ARISING FROM BURN INJURY BY ADMINISTERING PDE4B-SELECTIVE INHIBITORS | 2019-05-30 |
20190160065 | Combined Hair Loss Inhibition Treatment | 2019-05-30 |
20190160066 | THERAPEUTIC AGENT FOR LUNG CANCER THAT HAS ACQUIRED EGFR-TKI RESISTANCE | 2019-05-30 |
20190160067 | ANTI-HTLV-1 DRUG AND THERAPEUTIC AGENT FOR HTLV-1-ASSOCIATED MYELOPATHY/TROPICAL SPASTIC PARAPARESIS (HAM/TSP) | 2019-05-30 |
20190160068 | TREATMENT OF HAIR LOSS DISORDERS WITH DEUTERATED JAK INHIBITORS | 2019-05-30 |
20190160069 | PHARMACEUTICAL COMBINATIONS | 2019-05-30 |
20190160070 | DRY BLEND FORMULATION OF TETRAHYDROBIOPTERIN | 2019-05-30 |
20190160071 | THIENO- AND PYRROLOPYRIMIDINE ANALOGUES AND PRODRUGS THEREOF AS ANTICANCER AGENTS AND METHODS OF USE THEREOF | 2019-05-30 |
20190160072 | PHARMACEUTICAL COMBINATIONS FOR TREATING CANCER | 2019-05-30 |
20190160073 | Composition For Treating Or Preventing Liver Cancer | 2019-05-30 |
20190160074 | USE OF SODIUM CHANNEL BLOCKERS FOR THE TREATMENT OF NEUROPATHIC PAIN DEVELOPING AS A CONSEQUENCE OF CHEMOTHERAPY | 2019-05-30 |
20190160075 | COMBINATION OF HISTAMINE-3 RECEPTOR INVERSE AGONISTS WITH ACETYLCHOLINESTERASE INHIBITORS | 2019-05-30 |
20190160076 | METHODS AND COMPOSITIONS FOR TREATING HYPERTRIGLYCERIDEMIA | 2019-05-30 |
20190160077 | TRANSDERMAL PHARMACEUTICAL COMPOSITIONS COMPRISING ACTIVE AGENTS | 2019-05-30 |
20190160078 | GANAXOLONE FOR USE IN TREATING GENETIC EPILEPTIC DISORDERS | 2019-05-30 |
20190160079 | USE OF A BISPHOSPHONATE SALT IN A MEDICAMENT FOR A NATURALLY OCCURRING DISEASE/DISORDER IN A MAMMAL | 2019-05-30 |
20190160080 | NERIDRONIC ACID FOR TREATING COMPLEX REGIONAL PAIN SYNDROME | 2019-05-30 |
20190160081 | BORON CONTAINING SMALL MOLECULES AS ANTI-INFLAMMATORY AGENTS | 2019-05-30 |
20190160082 | NUTRITIONAL COMPOSITIONS WITH 2FL AND LNNT FOR USE IN PREVENTING AND/OR TREATING NON-ROTAVIRUS DIARRHEA BY ACTING ON THE GUT MICROBIOTA DYSBIOSIS | 2019-05-30 |
20190160083 | CATECHOLAMINE PRODRUGS FOR USE IN THE TREATMENT OF PARKINSON'S DISEASE | 2019-05-30 |
20190160084 | METHODS FOR THE TREATMENT OF CANCER USING MEGLUMINE | 2019-05-30 |
20190160085 | USE OF CYANOGLUCOSIDES AND PHARMACEUTICAL FORMULATIONS THEREOF IN THE TREATMENT OF DIABETES | 2019-05-30 |
20190160086 | METHODS FOR TREATING PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS | 2019-05-30 |
20190160087 | SUSTAINED RELEASE OF ANTIINFECTIVES | 2019-05-30 |
20190160088 | Uttroside B and Derivatives Thereof as Therapeutics for Hepatocellular Carcinoma | 2019-05-30 |
20190160089 | COMBINATION TREATMENT WITH ANTIBODY-DRUG CONJUGATES AND CYTARABINE | 2019-05-30 |
20190160090 | COMPOUNDS AND METHODS FOR MODULATING ANGIOTENSINOGEN EXPRESSION | 2019-05-30 |
20190160091 | COMPOSITIONS AND METHODS FOR TREATING HUNTINGTON'S DISEASE | 2019-05-30 |
20190160092 | Advanced Functional Biocompatible Polymeric Matrix Used as a Hemostatic Agent and System for Damaged Tissues and Cells | 2019-05-30 |
20190160093 | THERAPEUTIC AGENT FOR DISEASE ACCOMPANIED BY EPILEPTIC WAVES | 2019-05-30 |
20190160094 | METHOD FOR REDUCING OTOTOXICITY IN PEDIATRIC PATIENTS RECEIVING PLATINUM-BASED CHEMOTHERAPY | 2019-05-30 |
20190160095 | METHODS OF DETERRING CANINE COPROPHAGY | 2019-05-30 |